AbbVie Inc. (NYSE: ABBV) is a global research-based biopharmaceutical company that discovers, develops, manufactures and commercializes innovative medicines across immunology, oncology, neuroscience, eye care, aesthetics, virology and gastr…
HQ: North Chicago, IL, United States of Americawww.abbvie.com
USD295.03+0.20%vs prev. close
Performance
1W
+2.15%
1M
+7.32%
3M
+17.39%
1Y
+26.25%
YTD
+28.87%
Valuation
P/E
50.6
EPS TTM
5.83
Dividend yield
2.35%
Size and risk
Market cap
$521.5B
Beta
0.19
Price history
ABBV price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
AbbVie
ABBV
Drug Manufacturers - General
Mkt cap (USD bn)
521.5
P/E
50.6
Div yld
2.35%
1W
+2.1%
1M
+7.3%
3M
+17.4%
6M
+39.7%
1Y
+26.3%
YTD
+28.9%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
AbbVie
ABBV
Drug Manufacturers - General
521.5
50.6
2.35%
+2.1%
+7.3%
+17.4%
+39.7%
+26.3%
+28.9%
Subscribe to Equity Analytics to compare ABBV with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.